IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3310 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4740    
    Printed100    
    Emailed2    
    PDF Downloaded3    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2001  |  Volume : 67  |  Issue : 6  |  Page : 309--311

Evaluation on azathioprine in the treatment of parthenium dermatitis


1 Department of Dermatology, Dayanand Medical College and Hospital, Ludhiana, India
2 Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, India

Correspondence Address:
Shallu Khurana
161-E, Bhai Randhir Singh Nagar, Ludhiana-141 004
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17664785

Rights and PermissionsRights and Permissions

Parthenium dermatitis is one of the most intractable problems in dermatology, the management of which poses a therapeutic challenge. The mainstay of treatment has been systemic corticosteroids for prolonged periods which may result in various side-effects.ln the present study, 30 patients of parthenium dermatitis were treated with oral azathioprine in a dose of 1-3 mg/kg/day. Assessment was done at monthly intervals using a clinical score. Azathioprine emerged as an effective and safe corticosteroid sparing agent in the treatment of parthenium dermatitis, provided the patients are carefully monitored for the side effects.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow